Beware what the state pushes as therapy...

Are you getting the spike proteins second hand????? With God knows what else with the Monoclonal "Therapy."

~Bonnie

~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~

https://www.biorxiv.org/content/10.1101/2021.06.09.447527v1.full.pdf

Results

Identification of monoclonal antibodies neutralizing SARS-CoV-2
To isolate fully matured antibodies with high neutralizing potency against live SARS-CoV-2 virus, we immunized mice either with the recombinant Spike protein or its RBD. Screening of the best antibody-expressing mouse hybridoma clones generated from mice immunized with the viral Spike protein revealed that all except one (98%) target RBD of the SARS-CoV-2 S protein (Figure 1A). Nineteen out of 23 hybridoma clones from RBD-immunized mice produced antibodies recognizing the S protein (Figure 1B). Out of the 65 RBD- and Spike-positive hybridoma clone supernatants, thirteen inhibited the interaction between RBD and ACE2 in the
competition ELISA, twelve inhibited the interaction between the S protein and ACE2 expressed on the surface of HEK293T/17-hACE2 cells (the assay mimics the first step in the infection of
the human cells by SARS-CoV-2), twelve inhibited cell entry of replication-deficient mouse leukemia virus (MLV) pseudotyped with the SARS-CoV-2 spike protein, and thirteen neutralized the live authentic virus (Slovakia/SK-BMC5/2020 isolate, B.1 lineage) in PRNT